[Tolerance of Haemofusin in hemodilution and volume substitution].
In an open and uncontrolled trial the frequency and the type of adverse events were registered in patients who received Haemofusin, a hydroxyethyl starch solution, either for volume substitution or haemodilution. A total of 379 patients were investigated. No serious allergic reaction occurred. Headache, fever, rigor, light allergic reactions and nausea were documented in 17 patients. Even if one assumes that these observed concomitant events were caused by the hydroxyethyl starch, Haemofusin proved to be a well-tolerated colloid with a low rate of side effects (4.5%).
Kaniecki
K
K
Pfrimmer Kabi, Erlangen.
Biesel
E
E
Zielke
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006438:Hemodilution / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D011446:Prospective Studies
D006895:Hydroxyethyl Starch Derivatives
Untersuchungen zur Verträglichkeit von Haemofusin in der Hämodilution und Volumensubstitution.